The study of how genes influence a person's pharmacological reaction is known as pharmacogenomics. This field combines pharmacology (the science of pharmaceuticals) and genomics (the study of genes and their functions) to create effective, safe treatments depending on a person's genetic composition. Many current medications are "one size fits all," but they do not work in the same manner for everyone. It's difficult to know who will benefit from a medication, who won't, and who will have negative side effects (called adverse drug reactions). In the United States, adverse medication reactions are a leading cause of hospitalizations and deaths. Researchers are trying to figure out how genetic variations affect the body's response to drugs.

  • Food and Drug Administration.
  • Enzyme.
  • Drug Development.


    Related Conference of Pharmacogenomics

    July 04-05, 2023

    39th World Pharmacology and Therapeutics Forum

    Paris, France
    October 16-17, 2023

    19th Annual Congress on Pharmacology and Toxicology

    Tokyo, Japan

    Pharmacogenomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in